Allegion plc (NYSE:ALLE) Holdings Decreased by Amica Retiree Medical Trust

Amica Retiree Medical Trust lessened its stake in Allegion plc (NYSE:ALLE) by 20.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,280 shares of the scientific and technical instruments company’s stock after selling 322 shares during the period. Amica Retiree Medical Trust’s holdings in Allegion were worth $167,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of ALLE. Brooklyn Investment Group acquired a new stake in shares of Allegion in the third quarter valued at $28,000. Millstone Evans Group LLC acquired a new stake in Allegion in the 4th quarter valued at about $28,000. Atala Financial Inc bought a new position in shares of Allegion during the 4th quarter valued at about $35,000. Private Trust Co. NA grew its stake in shares of Allegion by 56.1% in the 4th quarter. Private Trust Co. NA now owns 320 shares of the scientific and technical instruments company’s stock worth $42,000 after purchasing an additional 115 shares during the last quarter. Finally, Tortoise Investment Management LLC raised its holdings in shares of Allegion by 78.0% in the 4th quarter. Tortoise Investment Management LLC now owns 388 shares of the scientific and technical instruments company’s stock worth $51,000 after purchasing an additional 170 shares in the last quarter. Institutional investors and hedge funds own 92.21% of the company’s stock.

Insider Activity

In related news, Director Gregg C. Sengstack purchased 8,000 shares of Allegion stock in a transaction on Wednesday, February 19th. The stock was bought at an average price of $125.24 per share, with a total value of $1,001,920.00. Following the completion of the transaction, the director now directly owns 8,000 shares of the company’s stock, valued at approximately $1,001,920. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP David S. Ilardi sold 789 shares of the stock in a transaction dated Tuesday, March 4th. The shares were sold at an average price of $125.28, for a total value of $98,845.92. Following the transaction, the senior vice president now directly owns 9,625 shares in the company, valued at approximately $1,205,820. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 3,224 shares of company stock worth $406,636 in the last three months. 0.33% of the stock is owned by insiders.

Allegion Price Performance

Shares of ALLE opened at $130.44 on Thursday. The company has a debt-to-equity ratio of 1.32, a current ratio of 2.04 and a quick ratio of 1.43. The company has a market capitalization of $11.26 billion, a price-to-earnings ratio of 19.13, a P/E/G ratio of 3.97 and a beta of 1.11. The business’s 50-day moving average is $129.70 and its 200-day moving average is $136.34. Allegion plc has a fifty-two week low of $113.27 and a fifty-two week high of $156.10.

Allegion (NYSE:ALLE) last released its earnings results on Tuesday, February 18th. The scientific and technical instruments company reported $1.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.75 by $0.11. Allegion had a net margin of 15.84% and a return on equity of 45.12%. The company had revenue of $945.60 million during the quarter, compared to the consensus estimate of $938.91 million. Equities research analysts expect that Allegion plc will post 7.77 EPS for the current fiscal year.

Allegion Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Friday, March 14th will be paid a dividend of $0.51 per share. The ex-dividend date is Friday, March 14th. This is an increase from Allegion’s previous quarterly dividend of $0.48. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.56%. Allegion’s dividend payout ratio (DPR) is 29.91%.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on ALLE shares. Morgan Stanley lifted their price target on shares of Allegion from $137.00 to $139.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 19th. Robert W. Baird cut their target price on Allegion from $152.00 to $144.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 19th. Barclays decreased their price target on Allegion from $130.00 to $126.00 and set an “underweight” rating for the company in a research report on Wednesday. StockNews.com downgraded Allegion from a “buy” rating to a “hold” rating in a report on Friday, March 7th. Finally, Wells Fargo & Company decreased their target price on shares of Allegion from $140.00 to $135.00 and set an “equal weight” rating for the company in a report on Wednesday, February 19th. One analyst has rated the stock with a sell rating and six have issued a hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $137.67.

Allegion Company Profile

Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door controls and systems and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors, accessories, and other.